Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

In-silico Studies, Synthesis, and Antacid Activities of Magnesium (II) Complexes

Author(s): Basuki Nath Jha, Richa Kothari and Anurag Agrawal*

Volume 21, Issue 6, 2024

Published on: 20 March, 2024

Article ID: e200324228146 Pages: 11

DOI: 10.2174/0115701638276401240315084143

Price: $65

Abstract

Background: Nowadays, acidity is a severe problem worldwide caused by excessive gastric acid secretion by the stomach and proximal intestine.

Objective: Antacids are drugs capable of buffering stomach acid. Therefore, in our research work, we have reported the in-silico studies, synthesis, characterization, and evaluation of antacid activities of magnesium (II) complexes via the acid-base neutralization process.

Methods: In this research, some magnesium complexes were synthesized and their antacid behavior was compared with marketed products. Also, in-silico studies were performed on H+/K+ ATPase (Proton pump). All synthesized compounds were characterized by various spectroscopic techniques like UV-Vis, FT-IR, XRD, and DSC techniques.

Result: Spectroscopic analysis results showed that the semicarbazone ligand shows keto-enol isomerism and forms a coordinated stable complex with magnesium ions in the crystalline phase. The FT-IR results confirmed the presence of Mg-O stretching, N-H bending, and C=N stretching vibrations in Mg (II) complexes.

Conclusion: The antacid activities of Mg (II) complexes were excellent as compared to the semicarbazone ligand and comparable with that of marketed antacid drugs like ENO, and Pantop-D. Insilco studies also confirmed that semicarbazone ligand and its Mg (II) complexes were both found to be fitted into the active sites of molecular targets, and Mg (II) complexes showed better binding affinities towards macromolecular as compared to semicarbazone ligand.

Graphical Abstract

[1]
Pal R, Kumar V, Gupta AK, Beniwal V. Synthesis, characterization and DNA photocleavage study of a novel dehydroacetic acid based hydrazone Schiff’s base and its metal complexes. Med Chem Res 2014; 23(7): 3327-35.
[http://dx.doi.org/10.1007/s00044-014-0911-6]
[2]
Padhyé S, Kauffman GB. Transition metal complexes of semicarbazones and thiosemicarbazones. Coord Chem Rev 1985; 63: 127-60.
[http://dx.doi.org/10.1016/0010-8545(85)80022-9]
[3]
Abu-Dief AM, Mohamed IMA. A review on versatile applications of transition metal complexes incorporating Schiff bases. Beni Suef Univ J Basic Appl Sci 2015; 4(2): 119-33.
[PMID: 32289037]
[4]
Casas JS, García-Tasende MS, Sordo J. Main group metal complexes of semicarbazones and thiosemicarbazones. A structural review. Coord Chem Rev 2000; 209(1): 197-261.
[http://dx.doi.org/10.1016/S0010-8545(00)00363-5]
[5]
Beraldo H. Semicarbazone and thiosemicarbazones: The broad pharmacological profile and clinical uses. Chem New 2004; 27(3): 461-71.
[6]
Beraldo H, Gambino D. The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. Mini Rev Med Chem 2004; 4(1): 31-9.
[http://dx.doi.org/10.2174/1389557043487484] [PMID: 14754441]
[7]
More MS, Joshi PG, Mishra YK, Khanna PK. Metal complexes driven from Schiff bases and semicarbazones for biomedical and allied applications: A review. Mater Today Chem 2019; 14: 100195.
[http://dx.doi.org/10.1016/j.mtchem.2019.100195] [PMID: 32289101]
[8]
Salem NMH, Rashad AR, Sayed LE, et al. Synthesis, characterization, molecular structure and supramolecular architectures of some copper(II) complexes derived from salicylaldehydesemicarbazone. In organica Chim Acta 2015; 432: 231-42.
[9]
Shaabani B, Khandar AA, Mahmoudi F, Maestro MA, Balula SS, Cunha-Silva L. Novel binuclear Cu(II) complexes combining a semicarbazone schiff base with distinct bridging ligands: Structure and antimicrobial activity. Polyhedron 2013; 57: 118-26.
[http://dx.doi.org/10.1016/j.poly.2013.04.016]
[10]
Abdolhi N, Aghaei M, Soltani A, et al. Synthesis and antibacterial activities of novel Hg(II) and Zn(II) complexes of bis(thiosemicarbazone) acenaphthenequinone loaded to MWCNTs. J Struct Chem 2019; 60(5): 845-53.
[http://dx.doi.org/10.1134/S0022476619050196]
[11]
Muleta F, Alansi T, Eswaramoorthy R. A review on synthesis, characterization methods and Biological activities of Semicarbazone, Thiosemi-Carbazone and their transition metal complexes. J Nat SciRes 2019; 9(17): 33-46.
[12]
Cavalcanti de Queiroz A, Alves MA, Barreiro EJ, Lima LM, Moreira AMS. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis. Exp Parasitol 2019; 201: 57-66.
[http://dx.doi.org/10.1016/j.exppara.2019.04.003] [PMID: 31004571]
[13]
Todorović TR, Vukašinović J, Portalone G, et al. (Chalcogen)semicarbazones and their cobalt complexes differentiate HL-60 myeloid leukaemia cells and are cytotoxic towards tumor cell lines. MedChemComm 2017; 8(1): 103-11.
[http://dx.doi.org/10.1039/C6MD00501B] [PMID: 30108695]
[14]
Machado I, Fernández S, Becco L, et al. New fac -tricarbonyl rhenium(I) semicarbazone complexes: Synthesis, characterization, and biological evaluation. J Coord Chem 2014; 67(10): 1835-50.
[http://dx.doi.org/10.1080/00958972.2014.926008]
[15]
Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C. Advances in copper complexes as anticancer agents. Chem Rev 2014; 114(1): 815-62.
[http://dx.doi.org/10.1021/cr400135x] [PMID: 24102434]
[16]
Qi J, Liang S, Gou Y, et al. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism. Eur J Med Chem 2015; 96: 360-8.
[http://dx.doi.org/10.1016/j.ejmech.2015.04.031] [PMID: 25899339]
[17]
Venkatachalam TK, Bernhardt PV, Noble CJ, et al. Synthesis, characterization and biological activities of semicarbazones and their copper complexes. J Inorg Biochem 2016; 162: 295-308.
[http://dx.doi.org/10.1016/j.jinorgbio.2016.04.006] [PMID: 27138101]
[18]
Marzano C, Pellei M, Tisato F, Santini C. Copper complexes as anticancer agents. Anticancer Agents Med Chem 2009; 9(2): 185-211.
[http://dx.doi.org/10.2174/187152009787313837] [PMID: 19199864]
[19]
Gatto CC, Lima IJ, Chagas MAS. Supramolecular architectures and crystal structures of gold(III) compounds with semicarbazones. Supramol Chem 2017; 29(4): 296-307.
[http://dx.doi.org/10.1080/10610278.2016.1227440]
[20]
Suryakumari Ch, Reddy AD, Durgarao G, et al. Formulation and evaluation of poly herbal drugs powder by using antacid and anti-ulcer treatment. J Glob Trends Pharm Sci 2021; 12(2): 9498-505.
[21]
Sharma S, Sharma P, Katiyar D, Goel R, Sahoo J. Formulation, standardization and screening of polyherbal churna for antacid activity. Int J Res Ayurveda Pharm 2018; 9(4): 94-7.
[http://dx.doi.org/10.7897/2277-4343.094119]
[22]
Kothari R, Sen S, Rai S. Green synthesis of cobalt sulphide nanoparticles using synthesised cobalt (II) complex as a single route intermediate. Dig J Nanomater Biostruct 2022; 17(2): 403-20.
[http://dx.doi.org/10.15251/DJNB.2022.172.403]
[23]
Fiorentini D, Cappadone C, Farruggia G, Prata C. Magnesium: Biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients 2021; 13(4): 1136.
[http://dx.doi.org/10.3390/nu13041136] [PMID: 33808247]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy